Potent α-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris

Archives of Pharmacal Research

Volumn 36, Issue 5, 2013, Pages 542-552

  Nurul Islam, Md ^a   Jung, Hyun Ah ^b   Sohn, Hee Sook ^b   Kim, Hye Mi ^b   Choi, Jae Sue ^a  

^a Pukyong National University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Glucosidase; Artemisia capillaris; Coumarin; Flavonoid; PTP1B

Indexed keywords

3 GLUCOISIDE; 3 ROBINOBIOSIDE; 6 METHOXY ARTEMICAPIN C; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; ARCAPILLIN; ARTEMISIA CAPILLARIS EXTRACT; CHLOROGENIC ACID; CIRSILINEOL; COUMARIN DERIVATIVE; CYNARINE; DAPHNETIN; ESCULETIN; ESCULIN; FLAVONOID; HERNIARIN; HYPERIN; ISORHAMNETIN; ISOSCOPOLIN; LINARIN; PHENOL DERIVATIVE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; QUERCETIN; SCOPARONE; SCOPOLETIN; SCOPOLIN; UMBELLIFERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIDIABETIC ACTIVITY; ARTEMISIA; ARTEMISIA CAPILLARIS; ARTICLE; BIOLOGICAL ACTIVITY; COLUMN CHROMATOGRAPHY; DIABETES MELLITUS; FRACTIONATION; IC 50; MEDICINAL PLANT; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ALPHA-GLUCOSIDASES; ARTEMISIA; DRUG DISCOVERY; ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; MOLECULAR STRUCTURE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84878253241     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0069-7     Document Type: Article

References (41)

1. Korea Food and Drug Administration. 2002. The Korean herbal pharmacopoeia, 307, 383, 461, 505. Seoul: Korea Food and Drug Administration.
2. World Health Organization (WHO). 2008. 10 Facts about diabetes. Available at http://www.who.int/features/factfiles/diabetes/10-en.html. Accessed 15 June 2008.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. 2010. Division of Health Interview Statistics, data from the National Health Interview Survey. U.S. Bureau of the Census, census of the population and population estimates. Available from http://www.cdc.gov/diabetes/ statistics/. Accessed Oct 2010.
4. Adolfo, A.C.; and H. Michael. 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of Ethnopharmacology 99: 325-348.
5. Ashraf, M.; M.Q. Hayat, S. Jabeen, N. Shaheen, M.A. Khan, G. Yasmin, and L. Artemisia. 2010. Species recognized by the local community of northern areas of Pakistan as folk therapeutic plants. Journal of Medicinal Plants Research 4: 112-119.
6. Ayodhya, S.; S. Kusum, and S. Anjali. 2010. Hypoglycaemic activity of different extracts of various herbal plants. International Journal of Research in Ayurveda and Pharmacy 1: 212-224.
7. Chaudhry, J.; N.N. Ghosha, K. Roya, and R. Chandra. 2007. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sciences 80: 1135-1142.
8. Cui, C.B.; S.K. Jeong, Y.S. Lee, S.O. Lee, I.J. Kang, and S.S. Lim. 2009. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princeps on rat lens aldose reductase and on the formation of advanced glycation end products. Journal of the Korean Society for Applied Biological Chemistry 52: 655-662.
9. Cui, L.; M.K. Na, H. Oh, E.Y. Bae, D.G. Jeong, S.E. Ryu, S. Kim, B.Y. Kim, W.K. Oha, and J.S. Ahn. 2006. Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorganic & Medicinal Chemistry Letters 16: 1426-1429.
10. Fujisawa, T.; H. Ikegami, K. Inoue, Y. Kawabata, and T. Ogihara. 2005. Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism: Clinical and Experimental 54: 387-390.
11. Gao, H.; Y.N. Huang, B. Gao, P.Y. Xu, C. Inagaki, and J. Kawabata. 2008. α-Glucosidase inhibitory effect by the flower buds of Tussilago farfara L. Food Chemistry 106: 1195-1201.
12. Herz, W.; S.V. Bhat, and P.S. Santhanam. 1970. Coumarins of Artemisia dracunculoides and 3′,6-dimethoxy-4′,5,7-trihydroxyflavone in A. arctica. Phytochemistry 9: 891-894.
13. Johnson, T.O.; J. Ermolieff, and M.R. Jirousek. 2002. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nature Reviews Drug Discovery 1: 696-709.
14. Jung, H.A.; M.N. Islam, Y.K. Kwon, S.E. Jin, Y.K. Son, J.J. Park, H.S. Sohn, and J.S. Choi. 2011. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food and Chemical Toxicology 49: 376-384.
15. Jung, H.A.; J.J. Park, M.N. Islam, S.E. Jin, B.S. Min, J.H. Lee, H.S. Sohn, and J.S. Choi. 2012. Inhibitory activity of coumarins from Artemisia capillaris against advanced glycation endproduct formation. Archives of Pharmacal Research 35: 1021-1035.
16. Kim, J.O.; Y.S. Kim, J.H. Lee, M.N. Kim, S.H. Rhee, S.H. Moon, and K.Y. Park. 1992. Antimutagenic effect of the major volatile compounds identified from mugwort (Artemisia asiatica nakai) leaves. Journal of the Korean Society of Food Science and Nutrition 21: 308-313.
17. Kim, J.S.; C.S. Kwon, and K.H. Son. 2000. Inhibition of alpha glucosidase and amylase by luteolin, a flavonoid. Bioscience, Biotechnology, and Biochemistry 64: 2458-2461.
18. Kim, T.J. 1996. Korean resources plants, 265. Seoul: Seoul National University Press.
19. Kimura, Y.; H. Okuda, T. Okuda, T. Hatano, I. Agata, and S. Arichi. 1985. Studies on the activities of tannins and related compounds from medicinal plants and drugs. VII. Effects of extracts of leaves of Artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil. Chemical & Pharmaceutical Bulletin 33: 2028-2034.
20. Komiya, T.; Y. Naruse, and H. Oshio. 1976. Studies on "Inchinko". II. Studies on the compounds related to capillarisin and flavonoids. Yakugaku Zasshi 96: 855-862.
21. Kordali, S.; R. Kotan, A. Mavi, A. Cakir, A. Ala, and A. Vildirim. 2005. Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils. Journal of Agriculture and Food Chemistry 53: 9452-9458.
22. Kumar, S.; S. Narwal, V. Kumar, and O. Prakash. 2011. α-Glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacognosy Reviews 5: 19-29.
23. Lee, S.; K.S. Kim, S.H. Shim, Y.M. Park, and B.K. Kim. 2003. Constituents from the non-polar fraction of Artemisia apiacea. Archives of Pharmacal Research 26: 902-905.
24. Li, T.; X.D. Zhang, Y.W. Song, and J.W. Liu. 2005. A microplate-based screening method for α-glucosidase inhibitors. Chinese Journal of Clinical Pharmacology and Therapeutics 10: 1128-1134.
25. Logendra, S.; D. Ribnicky, H. Yang, A. Poulev, J. Ma, E. Kennelly, and I. Raskin. 2006. Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 67: 1539-1546.
26. Mehrdad, I.; A.E. Seyed, and M.S. Meysam. 2007. Detection of sesquiterpene lactones in ten Artemisia species population of Khorasan Provinces. Iranian Journal of Basic Medical Sciences 10: 183-188.
27. Okada, Y.; N. Miyauchi, K. Suzuki, T. Kobayashi, C. Tsutsui, K. Mayuzumi, S. Nishibe, and T. Okuyama. 1995. Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation. Chemical & Pharmaceutical Bulletin 43: 1385-1387.
28. Panunti, B.; A.A. Jawa, and V.A. Fonseca. 2004. Mechanisms and therapeutic targets in type 2 diabetes mellitus. Drug Discover Today: Disease Mechanisms 1: 151-157.
29. Proksch, P. 1992. Artemisia. In Hagers Handbuch der Pharmazeutischen Praxis, ed. R. Hansel, K. Keller, H. Rimpler, G. Schneider, and Hrsg, 357-377. Berlin: Springer-Verlag.
30. Ribnickya, D.M.; A. Pouleva, M. Watfordb, W.T. Cefaluc, and I. Raskina. 2006. Antihyperglycemic activity of Tarralin™, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 13: 550-557.
31. Saltiel, A.R.; and J.E. Pessin. 2002. Insulin signaling pathways in time and space. Trends in Cell Biology 12: 65-71.
32. Singh, K.; P.K. Rai, D. Jaiswal, and G. Watal. 2008. Evidence based critical evaluation of glycemic potential of Cynodon dactylon. Evidence-Based Complementary and Alternative Medicine 5: 415-420.
33. Standl, E.; and O. Schnell. 2012. Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation. Diabetes and Vascular Disease Research 9: 163-169.
34. Tadera, K.; Y. Minami, K. Takamatsu, and T. Matsouka. 2006. Inhibition of α-glucosidase and α-amylase by flavonoids. Journal of Nutritional Science and Vitaminology 52: 149-153.
35. Tan, R.X.; W.F. Zheng, and H.Q. Tang. 1998. Biologically active substances from the genus Artemisia. Planta Medica 64: 295-302.
36. Tonks, N.K.; and B.G. Neal. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Current Opinion in Cell Biology 13: 182-195.
37. Vats, R.K.; V. Kumar, A. Kothari, and A. Mital. 2005. Emerging targets for diabetes. Current Science 88: 241-249.
38. Wu, T.S.; Z.J. Tsang, P.L. Wu, F.W. Lin, C.Y. Li, C.M. Teng, and K.H. Lee. 2001. New constituents and antiplatelet aggregation and anti-HIV principles of Artemisia capillaris. Bioorganic & Medicinal Chemistry 9: 77-83.
39. Wu, X.; V.E. Hardy, and J.I. Joseph. 2003. Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition. Metabolism 52: 705-712.
40. Yook, C.S. 1989. Coloured medicinal plants of Korea, 522. Seoul: Academy Publishing Co.
41. Zhao, Q.C.; H. Kiyohara, and H. Yamada. 1994. Anti-complementary neutral polysaccharides from leaves of Artemisia princeps. Phytochemistry 35: 73-77.